Pharmacyclics’ blood cancer drug responses rise (Reuters)
Reuters – Interim results from an early stage trial of Pharmacyclics Inc’s experimental blood cancer drug show the number of leukemia patients responding to the medicine has increased over time.
View full post on Yahoo! News: Health News
Leave a Reply